Suppr超能文献

器官纤维化的解决。

Resolution of organ fibrosis.

出版信息

J Clin Invest. 2018 Jan 2;128(1):97-107. doi: 10.1172/JCI93563.

Abstract

Fibrosis is the excessive accumulation of extracellular matrix that often occurs as a wound healing response to repeated or chronic tissue injury, and may lead to the disruption of organ architecture and loss of function. Although fibrosis was previously thought to be irreversible, recent evidence indicates that certain circumstances permit the resolution of fibrosis when the underlying causes of injury are eradicated. The mechanism of fibrosis resolution encompasses degradation of the fibrotic extracellular matrix as well as elimination of fibrogenic myofibroblasts through their adaptation of various cell fates, including apoptosis, senescence, dedifferentiation, and reprogramming. In this Review, we discuss the present knowledge and gaps in our understanding of how matrix degradation is regulated and how myofibroblast cell fates can be manipulated, areas that may identify potential therapeutic approaches for fibrosis.

摘要

纤维化是细胞外基质的过度积累,通常发生在组织反复或慢性损伤的愈合反应中,可能导致器官结构的破坏和功能丧失。虽然纤维化以前被认为是不可逆转的,但最近的证据表明,在损伤的根本原因被消除的情况下,某些情况下允许纤维化的消退。纤维化消退的机制包括纤维化细胞外基质的降解以及通过肌成纤维细胞的各种细胞命运的适应来消除肌成纤维细胞,包括细胞凋亡、衰老、去分化和重编程。在这篇综述中,我们讨论了目前对基质降解如何受到调控以及肌成纤维细胞的细胞命运如何被操纵的认识上的空白,这些领域可能为纤维化的潜在治疗方法提供线索。

相似文献

1
Resolution of organ fibrosis.
J Clin Invest. 2018 Jan 2;128(1):97-107. doi: 10.1172/JCI93563.
2
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.
Cells. 2021 Oct 15;10(10):2759. doi: 10.3390/cells10102759.
4
The myofibroblast matrix: implications for tissue repair and fibrosis.
J Pathol. 2013 Jan;229(2):298-309. doi: 10.1002/path.4104.
5
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging.
Am J Respir Cell Mol Biol. 2020 May;62(5):633-644. doi: 10.1165/rcmb.2019-0092OC.
6
Host responses in tissue repair and fibrosis.
Annu Rev Pathol. 2013 Jan 24;8:241-76. doi: 10.1146/annurev-pathol-020712-163930. Epub 2012 Oct 22.
7
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Nat Rev Rheumatol. 2020 Jan;16(1):11-31. doi: 10.1038/s41584-019-0324-5. Epub 2019 Dec 2.
8
Matrix Stiffness: the Conductor of Organ Fibrosis.
Curr Rheumatol Rep. 2018 Jan 19;20(1):2. doi: 10.1007/s11926-018-0710-z.
9
p53 and Myofibroblast Apoptosis in Organ Fibrosis.
Int J Mol Sci. 2023 Apr 4;24(7):6737. doi: 10.3390/ijms24076737.
10
Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Exp Biol Med (Maywood). 2018 Apr;243(7):601-612. doi: 10.1177/1535370218761628. Epub 2018 Mar 4.

引用本文的文献

2
Fibroblast activation and heterogeneity in fibrotic disease.
Nat Rev Nephrol. 2025 Jun 19. doi: 10.1038/s41581-025-00969-8.
4
lncRNA TUG1 and kidney diseases.
BMC Nephrol. 2025 Mar 20;26(1):139. doi: 10.1186/s12882-025-04047-w.
6
Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.
J Transl Med. 2025 Feb 27;23(1):240. doi: 10.1186/s12967-024-06060-3.
7
Molecular dissection of tendon development and healing: Insights into tenogenic phenotypes and functions.
J Biol Chem. 2025 Apr;301(4):108353. doi: 10.1016/j.jbc.2025.108353. Epub 2025 Feb 25.
8
State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy.
J Respir Biol Transl Med. 2025 Mar;2(1). doi: 10.70322/jrbtm.2024.10023. Epub 2024 Dec 16.
9
The Novel Effect and Potential Mechanism of Lactoferrin on Organ Fibrosis Prevention.
Nutrients. 2025 Jan 6;17(1):197. doi: 10.3390/nu17010197.
10
Physical Exercise: A Promising Treatment Against Organ Fibrosis.
Int J Mol Sci. 2025 Jan 2;26(1):343. doi: 10.3390/ijms26010343.

本文引用的文献

1
Mesenchymal Stem Cells in Fibrotic Disease.
Cell Stem Cell. 2017 Aug 3;21(2):166-177. doi: 10.1016/j.stem.2017.07.011.
2
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis .
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.02367-2016. Print 2017 Aug.
3
F4/80+ Macrophages Contribute to Clearance of Senescent Cells in the Mouse Postpartum Uterus.
Endocrinology. 2017 Jul 1;158(7):2344-2353. doi: 10.1210/en.2016-1886.
4
Mechanisms of hepatic stellate cell activation.
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.
5
Redefining the identity of cardiac fibroblasts.
Nat Rev Cardiol. 2017 Aug;14(8):484-491. doi: 10.1038/nrcardio.2017.57. Epub 2017 Apr 24.
6
Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis.
Mol Cell Biol. 2017 May 31;37(12). doi: 10.1128/MCB.00565-16. Print 2017 Jun 15.
7
Cellular senescence mediates fibrotic pulmonary disease.
Nat Commun. 2017 Feb 23;8:14532. doi: 10.1038/ncomms14532.
8
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.
J Clin Invest. 2017 Feb 1;127(2):405-414. doi: 10.1172/JCI87440.
9
Fibroblast Senescence and Apoptosis. "One-Two Punch" to Slow Down Lung Fibrosis?
Am J Respir Cell Mol Biol. 2017 Feb;56(2):145-146. doi: 10.1165/rcmb.2016-0387ED.
10
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
Gut. 2017 Sep;66(9):1697-1708. doi: 10.1136/gutjnl-2016-312473. Epub 2017 Jan 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验